Bone grafts help millions of people suffering from bone loss due to trauma or disease. Typically, traumatic bone injuries and bone loss due to disease have been mended with synthetic grafts or segments of bone taken from another area in the patient’s body. However, these treatments do not last long-term in growing bodies, and lack vasculature required for mature bone growth. In vitro tests at the New York Stem Cell Foundation Research Institute of a new technology called Segmental Additive Tissue Engineering (SATE) have demonstrated stem cell grown segments of bone creating large scale, personalized grafts. The SATE protocol seeds the patient’s own stem cells into a scaffold and directs the cells to develop into customized and vascularized bone segments, which pose virtually no risk of rejection, and are able to grow with the patient.
Susan Solomon, CEO of the New York Stem Cell Foundation comments “We are hopeful that SATE will one day be able to improve the lives of the millions of people suffering from bone injury due to trauma, cancer, osteoporosis, osteonecrosis, and other devastating conditions… Our goal is to help these patients return to normal life, and by leveraging the power of regenerative medicine, SATE brings us one step closer to reaching that goal.”
With clinical trials soon underway, this advancement in bio-engineering will accelerate this trend and broaden applications to treat a wider variety of bone trauma. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.